MedPath

PET/CT Guided Robotic Arm-assisted Pain Palliation in Chronic Nociceptive Low Backache

Not Applicable
Completed
Conditions
Nociceptive Pain
Chronic Low-back Pain
Interventions
Procedure: F-18 sodium fluoride PET/CT guided robotic arm assisted injection of combination of local anesthetic and steroids
Registration Number
NCT05560165
Lead Sponsor
Post Graduate Institute of Medical Education and Research, Chandigarh
Brief Summary

A study to investigate the role of F-18 sodium fluoride in localizing the pain generator in participants with chronic nociceptive musculoskeletal low back ache and to study the use of PET/CT guided robotic arm assisted injection for targeted injection of a combination of corticosteroid and local anesthetic for pain palliation.

Detailed Description

Chronic pain in the lower back may be due to a variety of causes such as neuropathic causes, musculoskeletal causes, visceral causes, malignancy-related or primary pain where in there is no obvious cause of pain. Musculoskeletal pain usually affects the muscles, joints, bones or their surrounding soft tissue structures. These participants are usually evaluated with clinical examination and radiological imaging modalities such as computed tomography (CT) or Magnetic resonance imaging (MRI) to identify the pain generating site. The possible sites of involvement may include the sacroiliac joints, intervertebral facet joints, the vertebrae, the intervertebral discs, or the surrounding ligaments and muscles which may be apparent on imaging. They are usually started on oral analgesics such as Non-steroidal anti-inflammatory drugs as the first line of management. However, occasionally the patient may not respond to this line of management. In such cases, they may be treated with more potent analgesics or subjected to targeted local management of the pain-generating site with an injection of local anesthetics and corticosteroids. They are usually given at the site of tenderness following clinical examination or under image guidance using x-ray fluoroscopy or CT guidance. However, anatomical imaging modalities may not diagnose early stages of the disease or distinguish active from inactive disease. Bone scintigraphy with Tc-99m labeled phosphonates is known to diagnose and localize active sites of musculoskeletal pain. PET/CT with sodium fluoride is also useful in the same indication as it has similar pharmacodynamics to that of Tc-99m labeled phosphonates. The combination of image guidance with sodium fluoride PET/CT and the use of an automated robotic arm (ARA) can help in the targeted delivery of the local anesthetic and steroids to the nociceptive pain generating site. This study is intended to analyze the role of F-18 sodium fluoride in localizing the pain generator in participants with chronic nociceptive musculoskeletal low back ache and to study the use of PET/CT guided robotic arm assisted injection for targeted injection of steroid and local anesthetic for pain palliation in such participants.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
85
Inclusion Criteria
  • Participants with chronic nociceptive low back ache (for more than three months) do not have adequate pain relief with oral analgesics.
  • Participants who are ready to give written informed consent for the procedure
Exclusion Criteria
  • MRI showing the neuropathic cause of pain with spinal cord or nerve root compression.
  • Extensive bone or joint destruction and displacement such as spondylolisthesis or compression fractures of the vertebra.
  • Imaging, clinical and hematological findings suggestive of infective/ malignant pathology.
  • Patients with deranged coagulation profile
  • Pregnant and lactating women

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
PET/CT guided injection of combination of local anesthetic and steroids.F-18 sodium fluoride PET/CT guided robotic arm assisted injection of combination of local anesthetic and steroidsThe F-18 Sodium fluoride (NaF) dose will be administered intravenously and the F-18 NaF PET/CT images will be reviewed, and the target nociceptive site will be determined on the basis of increased focal tracer uptake. The joint accessibility, location, and relation with the nearby vital organs will be assessed. The injection will be assisted using a dedicated automated robotic arm system. A combination of corticosteroids and local anesthetic will be injected.
Primary Outcome Measures
NameTimeMethod
Diagnostic efficacy of the procedureImmediate - post procedure

Diagnostic efficacy of F-18 sodium fluoride PET/CT for localizing the site of pain in patients with chronic nociceptive low back ache and assessing the reduction in pain following the procedure.The procedure will be believed as technically successful if there is a 50% decrease in the severity of pain following the procedure as assessed by the visual analogue score.

Treatment efficacy of the procedureOne month

Treatment efficacy of injection of a combination of corticosteroid and local anesthetic intraarticularly following localization by F-18 sodium fluoride PET/CT in patients with chronic nociceptive low back ache. The visual analog score will be used to document the sustained reduction in pain for one month following the procedure.

Secondary Outcome Measures
NameTimeMethod
Safety of F-18 sodium fluoride PET/CT guided robotic arm assisted injection of local anesthetic and steroids.Immediately following the procedure till 30 minutes and upto one month following the procedure

To assess the immediate and delayed adverse effects following the procedure upto a period of one month.

Imaging based response assessment following F-18 sodium fluoride PET/CT guided robotic arm assisted injection of local anesthetic and steroids.One month

To quantify the resolution or decrease in the intensity of the tracer uptake in the target joints to assess the objective response to injection of local anesthetic and steroids by using F-18 sodium fluoride PET/CT at one month following injection. The images will be compared with those acquired at baseline to assess the response.

Trial Locations

Locations (1)

Department of Nuclear Medicine, Post Graduate Institute of Medical Education and Research

🇮🇳

Chandigarh, India

© Copyright 2025. All Rights Reserved by MedPath